Patents by Inventor Yuanhao LV

Yuanhao LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline Compounds, Preparation Method, Use, and Pharmaceutical Composition Thereof
    Publication number: 20230110550
    Abstract: The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.
    Type: Application
    Filed: September 13, 2022
    Publication date: April 13, 2023
    Inventors: Heng XU, Xiaoguang Chen, Songwen LIN, Ming JI, Jing JIN, Deyu WU, Chunyang Wang, Yuanhao LV
  • Quinazoline Compounds, Preparation Method, Use, and Pharmaceutical Composition Thereof
    Publication number: 20230113478
    Abstract: The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.
    Type: Application
    Filed: September 13, 2022
    Publication date: April 13, 2023
    Inventors: Heng XU, Xiaoguang Chen, Songwen LIN, Ming JI, Jing JIN, Deyu WU, Chunyang Wang, Yuanhao LV
  • Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof
    Patent number: 11534443
    Abstract: The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: December 27, 2022
    Assignee: INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Heng Xu, Xiaoguang Chen, Songwen Lin, Ming Ji, Jing Jin, Deyu Wu, Chunyang Wang, Yuanhao Lv
  • Quinazoline Compounds, Preparation Method, Use, and Pharmaceutical Composition Thereof
    Publication number: 20210128559
    Abstract: The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.
    Type: Application
    Filed: December 26, 2017
    Publication date: May 6, 2021
    Inventors: Heng XU, Xiaoguang CHEN, Songwen LIN, Ming JI, Jing JIN, Deyu WU, Chunyang WANG, Yuanhao LV